secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001104659-23-074068
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte stockholders approve Amended 2022 Equity Incentive Plan, adding ~6.1M new shares
--------------------------------------------------------------------------------

- Stockholders voted 67.4M For, 9.1M Against (92.3% approval) to amend the 2022 Equity Incentive Plan.
- Amendment adds 6,069,000 new shares plus shares from prior plans to the share reserve.
- Total shares available under the plan will include up to 37.2M shares for Incentive Stock Options.
- Three directors elected: Art Mandell, Stanley Erck, Patrick Balthrop; all received majority votes.
- Ratification of CohnReznick LLP as independent auditor for FY2023 also approved (83.1M For).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/0001104659-23-074068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000110465923074068/tm2319527d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-074068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer